Your browser doesn't support javascript.
loading
A clinical review of viral hepatitis.
Loader, Michelle; Moravek, Rudolph; Witowski, Sarah E; Driscoll, Lynette M.
Affiliation
  • Loader M; At the University of Colorado School of Medicine in Aurora, Colo., Michelle Loader is a senior instructor in the Department of Medicine, Division of Hospital Gastroenterology and Hepatology; Rudolph Moravek and Sarah E. Witowski are instructors in the Department of Medicine, Division of Hospital Medicine; and Lynette M. Driscoll is an instructor in the Department of Surgery, Division of Transplant Surgery. The authors have disclosed no potential conflicts of interest, financial or otherwise.
JAAPA ; 32(11): 15-20, 2019 Nov.
Article in En | MEDLINE | ID: mdl-31592934
ABSTRACT
Viral hepatitis remains a significant public health problem in the United States, despite advances in antiviral therapy and effective vaccines. According to the CDC, about 20,000 deaths each year are attributed to viral hepatitis, and 5 million people are chronically infected and at risk for serious liver disease and hepatocellular cancer. This article reviews the three most common causes of viral hepatitis, screening guidelines, clinical features, medical management, approaches for primary prevention, and the natural history of untreated disease.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Mass Screening / Hepatitis, Viral, Human Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Mass Screening / Hepatitis, Viral, Human Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2019 Type: Article